Sami Nimer Malek, MD

Sami Nimer Malek, MD

Specialty: Hematology, Medical Oncology, Internal Medicine
Title: Professor
4.9/5
See All Ratings

To request an appointment call

734-647-8902
Sami Nimer Malek, MD
Sami Nimer Malek, MD
Hematology
  • About
  • Areas of Practice
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Research Overview
  • Manage Your Profile

  • About

    Dr. Malek is a physician scientist and professor of hematology/oncology working at the University of Michigan, Ann Arbor, USA. He obtained his MD from the University of Hamburg/Germany and subsequently trained in Molecular Biology at Johns Hopkins. He completed clinical training in Internal Medicine at Baylor College of Medicine and a combined fellowship in Hematology and Oncology at Johns Hopkins and Columbia University.

    Areas of Practice

    CLL clinical care and management, lymphoma therapy

    Locations

    • Lymphoma Clinic | Rogel Cancer Center 1500 E Medical Center Dr
      Floor B1 Reception A
      Ann Arbor, MI 48109-5911
      Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training

    Universitat Hamburg, 1991

    Residency

    Baylor College of Medicine, Internal Medicine, 2001

    Fellowships

    Johns Hopkins Hospital, Hematology/Medical Oncology, 2004

    Board Certifications

    Hematology

    Professional Organizations

    American Association for Cancer Research
    American Society of Hematology
    American Society of Clinical Investigation

    Research Overview

    The Malek lab is studying the genomics of hematological malignancies with long-standing interests in CLL, AML and Follicular Lymphoma. The research findings inform on the basic biology of blood cancers and allow for novel translational directions. Examples of work include the genomic characterization of CLL in various disease phases, the development of novel MRD assays in AML and the dynamics of AML evolution at relapse. Another programmatic focus area is the identification and functional characterization of recurrently mutated genes in FL and opportunities for FL targeting.